$SNPS

DE GEUS AART sold $21.4M of SNPS

DE GEUS AART (EXECUTIVE CHAIR) sold 49,641 shares of SYNOPSYS INC (SNPS) at an average of $430.68 ($419.44–$441.76, $21.38M total) across 2 trades over 2026-08-31 to 2026-09-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DE GEUS AART
Published Sep 2, 2026, 7:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 7:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SNPS
Bearish
medium confidence
Mentioned
$SNPS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNPSBearishMed
01

Why it matters

The disclosed sale could trigger short‑term selling pressure, but the pre‑arranged nature may limit its signaling value.

02

Market read

Primary insider sell provides fresh material information for traders evaluating SNPS.

03

What to watch

Potential tax planning or diversification motives could mitigate negative interpretation.

Relevance 6/10Novelty 7/10Timing: filing released after market close on 2026‑09‑02

Background

Form 4 filings disclose insider transactions; a sale of this size by the executive chair is noteworthy.

Company-level read

Ticker impact

$SNPSBearishMedium confidence
Context

Executive Chair Aart de Geus sold $21.4M of Synopsys shares via a 10b5‑1 plan, reducing his stake to 120,443 shares.

Expected impact

Possible modest downside pressure over the next few days.

Evidence & confidence

A $21M sale by the company's top executive is material and disclosed first via Form 4; markets often react to sizable insider disposals.

Market effects

May raise questions about Synopsys' growth outlook within the EDA sector.

Limited to U.S. tech equities; no broader regional effect.

Minimal global impact beyond Synopsys investors.

Counterpoint

The sale is pre‑arranged under a 10b5‑1 plan and may not reflect current sentiment.

Key entities

  • Synopsys Inc.

    U.S. listed provider of electronic design automation software (ticker SNPS).

  • Aart de Geus

    Executive Chair of Synopsys, filing a $21.4M share sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SNPSMedAI 8/10

Should $1b Amazon Deal Require Action From Synopsys (SNPS) Investors?

Synopsys (SNPS) announced a multiyear, $1B+ deal with Amazon to expand the use of its EDA, IP, and AI-based engineering tools for custom silicon. The agreement aligns with Synopsys' AI-centric roadmap and long-term financial goals. Analysts highlight potential demand visibility and capital allocation influences, while noting risks like Ansys integration and litigation. Current earnings are $1.1B, with forecasts for $2.6B by 2029, implying 13% yearly revenue growth.

$SNPSHigh

Synopsys (SNPS) Announces $1 Billion Accelerated Share Repurchas

Synopsys (SNPS) announced a $1 billion accelerated share repurchase agreement with JPMorgan Chase, aiming to buy back 1.7 million shares initially. The company's shares rose over 1% in pre-market trading. According to GuruFocus, SNPS is modestly undervalued by 24%, with a GF Value of $659.43. The company has a GF Score of 95/100, indicating strong financial health and growth potential. However, insider activity shows no purchases and $48.2 million in sales over the past year.